Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

390 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease.
Oza N, Takahashi H, Eguchi Y, Kitajima Y, Kuwashiro T, Ishibashi E, Nakashita S, Iwane S, Kawaguchi Y, Mizuta T, Ozaki I, Ono N, Eguchi T, Fujimoto K, Anzai K. Oza N, et al. Among authors: anzai k. Hepatol Res. 2014 Jul;44(7):812-7. doi: 10.1111/hepr.12176. Epub 2013 Jun 25. Hepatol Res. 2014. PMID: 23721476
The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease.
Eguchi Y, Mizuta T, Sumida Y, Ishibashi E, Kitajima Y, Isoda H, Horie H, Tashiro T, Iwamoto E, Takahashi H, Kuwashiro T, Soejima S, Kawaguchi Y, Oda Y, Emura S, Iwakiri R, Ozaki I, Eguchi T, Ono N, Anzai K, Fujimoto K, Koizumi S. Eguchi Y, et al. Among authors: anzai k. J Gastroenterol. 2011 Jan;46 Suppl 1:70-8. doi: 10.1007/s00535-010-0340-3. Epub 2010 Nov 2. J Gastroenterol. 2011. PMID: 21042922
Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis.
Oeda S, Mizuta T, Isoda H, Kuwashiro T, Oza N, Iwane S, Takahashi H, Kawaguchi Y, Eguchi Y, Toda S, Ozaki I, Anzai K, Fujimoto K. Oeda S, et al. Among authors: anzai k. Clin J Gastroenterol. 2012 Apr;5(2):141-5. doi: 10.1007/s12328-012-0295-4. Epub 2012 Mar 28. Clin J Gastroenterol. 2012. PMID: 22593772 Free PMC article.
Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels.
Yoneda M, Imajo K, Eguchi Y, Fujii H, Sumida Y, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Aoki N, Sata M, Kanemasa K, Kohgo Y, Saibara T, Chayama K, Itoh Y, Yoshikawa T, Anzai K, Fujimoto K, Okanoue T, Nakajima A; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD). Yoneda M, et al. Among authors: anzai k. J Gastroenterol. 2013 Sep;48(9):1051-60. doi: 10.1007/s00535-012-0704-y. Epub 2012 Nov 27. J Gastroenterol. 2013. PMID: 23184095
Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle.
Kitajima Y, Hyogo H, Sumida Y, Eguchi Y, Ono N, Kuwashiro T, Tanaka K, Takahashi H, Mizuta T, Ozaki I, Eguchi T, Kimura Y, Fujimoto K, Anzai K; Japan Nonalcoholic Fatty Liver Disease Study Group (JSG-NAFLD). Kitajima Y, et al. Among authors: anzai k. J Gastroenterol Hepatol. 2013 Sep;28(9):1507-14. doi: 10.1111/jgh.12227. J Gastroenterol Hepatol. 2013. PMID: 23577962
Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.
Nakahara T, Hyogo H, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Ono M, Kawaguchi T, Imajo K, Aikata H, Tanaka S, Kanemasa K, Fujimoto K, Anzai K, Saibara T, Sata M, Nakajima A, Itoh Y, Chayama K, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease. Nakahara T, et al. Among authors: anzai k. J Gastroenterol. 2014 Nov;49(11):1477-84. doi: 10.1007/s00535-013-0911-1. Epub 2013 Nov 26. J Gastroenterol. 2014. PMID: 24277052
390 results